R
Rakhi B. Shah
Researcher at Center for Drug Evaluation and Research
Publications - 47
Citations - 1929
Rakhi B. Shah is an academic researcher from Center for Drug Evaluation and Research. The author has contributed to research in topics: Drug delivery & Amberlite. The author has an hindex of 22, co-authored 45 publications receiving 1765 citations. Previous affiliations of Rakhi B. Shah include Food and Drug Administration & Texas Tech University Health Sciences Center.
Papers
More filters
Journal ArticleDOI
Comparative Evaluation of Flow for Pharmaceutical Powders and Granules
TL;DR: The objective of the present work was to carry out a systematic evaluation of flow of pharmaceutical powders and granules using compendial and non-compendial methods, and it was observed that the compendian methods were often non-discriminating for minor variations in powder flow.
Journal ArticleDOI
Process analytical technology (PAT) for biopharmaceutical products: Part II. Concepts and applications.
TL;DR: This two part series addresses PAT as it applies to processes that produce biotech therapeutic products and addresses evolution of the underlying concepts and applications in biopharmaceutical manufacturing.
Journal ArticleDOI
Optimization of a self-nanoemulsified tablet dosage form of Ubiquinone using response surface methodology: effect of formulation ingredients
Sami Nazzal,Mohammad T. H. Nutan,Anitha Palamakula,Rakhi B. Shah,Abdel-Azim Zaghloul,Mansoor A. Khan +5 more
TL;DR: The objectives of the present study were to evaluate the effect of formulation ingredients on the release rate of Ubiquinone from its adsorbing solid compact and to prepare and evaluate an optimized self-nanoemulsified tablet formulation.
Journal ArticleDOI
Application of quality by design elements for the development and optimization of an analytical method for protamine sulfate.
David Awotwe-Otoo,Cyrus Agarabi,Patrick J. Faustino,Muhammad J. Habib,Sau Lee,Mansoor A. Khan,Rakhi B. Shah +6 more
TL;DR: The results clearly showed that quality by design concept could be effectively applied to optimize an HPLC chromatographic method for protein analysis with the least number of experimental runs possible.
Journal ArticleDOI
Oral Delivery of Proteins: Progress and Prognostication
TL;DR: The progress in oral delivery of key therapeutic proteins and peptides, including insulin, calcitonin, interferons, human growth hormone, glucagons, gonadotropin-releasing hormones, enkephalins, vaccines, enzymes, hormone analogs, and enzyme inhibitors are reviewed.